Year | Year 1 | Year 2 | Year 3 | Cumulative |
---|---|---|---|---|
Biosimilar market share | 50% | 75% | 100% | Not applicable |
Budget for world without | €157,303,054 | €160,049,932 | €166,249,447 | €483,602,433 |
Budget for world with | €133,707,596 | €124, 038,697 | €116,374,613 | €374,120,906 |
Direct savings | €23,595,458 | €36,011,235 | €49,874,834 | €109,481,527 |
Additional Patients Treated | 2,581 | 3,940 | 5,456 | 11,977 |